Monthly information on share capital and company voting rights
Rhea-AI Impact
Rhea-AI Sentiment
Rhea-AI Summary
Cellectis (CLLS) reports a total number of shares in the capital and voting rights as of January 31, 2024. The company's ISIN code is FR0010425595 and is listed on Euronext Growth. Media and investor relations contacts are provided for further information.
Positive
- None.
Negative
- None.
(Article 223-16 of General Regulation of the French financial markets authority)
PARIS, Feb. 02, 2024 (GLOBE NEWSWIRE) --
Listing market: Euronext Growth
ISIN code: FR0010425595
| Date | Total number of shares in the capital | Total number of voting rights |
| 01/31/2024 | 71,751,201 | 77,686,818 |
For further information on Cellectis, please contact:
Media contact:
Pascalyne Wilson, Director, Communications, +33 (0)7 76 99 14 33, media@cellectis.com
Patricia Sosa Navarro, Chief of Staff to the CEO, +33 (0)7 76 77 46 93, media@cellectis.com
Investor Relations contacts:
Arthur Stril, Chief Business Officer, +1 (347) 809 5980, investors@cellectis.com
Ashley R. Robinson, LifeSci Advisors, +1 617 430 7577
Attachment
FAQ
What is the ISIN code for Cellectis?
The ISIN code for Cellectis is FR0010425595.
Where is Cellectis listed?
Cellectis is listed on Euronext Growth.
What are the total number of shares in the capital and voting rights reported by Cellectis?
As of January 31, 2024, Cellectis reported 71,751,201 shares in the capital and 77,686,818 voting rights.
Who are the media contacts for Cellectis?
The media contacts for Cellectis are Pascalyne Wilson and Patricia Sosa Navarro.
Who are the investor relations contacts for Cellectis?
The investor relations contacts for Cellectis are Arthur Stril and Ashley R. Robinson.
Cellectis